Health Care & Life Sciences » Pharmaceuticals | Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. | Ownership

Companies that own Cumberland Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Ariel Investments LLC
1,305,052
8.38%
291,126
0.08%
06/30/2018
Stonepine Capital Management LLC
1,203,339
7.73%
-119,702
4.26%
06/30/2018
Dimensional Fund Advisors LP
872,674
5.61%
-10,411
0%
06/30/2018
Renaissance Technologies LLC
377,209
2.42%
23,709
0%
06/30/2018
BlackRock Fund Advisors
328,814
2.11%
-1,907
0%
06/30/2018
The Vanguard Group, Inc.
311,109
2%
0
0%
06/30/2018
New York State Common Retirement Fund
260,730
1.68%
0
0%
06/30/2018
Bridgeway Capital Management, Inc.
205,400
1.32%
-78,300
0.01%
06/30/2018
Acadian Asset Management LLC
108,486
0.7%
1,164
0%
06/30/2018
Bard Associates, Inc.
79,615
0.51%
-3,600
0.22%
06/30/2018

About Cumberland Pharmaceuticals

View Profile
Address
2525 West End Avenue
Nashville Tennessee 37203
United States
Employees -
Website http://www.cumberlandpharma.com
Updated 07/08/2019
Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.